• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding

    The Baseline

    12
    Following
    368
    Stocks Tracked
    49
    Sectors & Interests
    Follow
    Load latest
    logo
    The Baseline
    15 Jul 2022
    Five Interesting Stocks Today

    Five Interesting Stocks Today

    1. MindTree: This mid-tier IT services company’s stock fell nearly 4% on Thursday, despite an over 5% sequential revenue growth on a constant currency basis in Q1FY23. In fact, its revenue in rupee terms rose over 7.5% QoQ to Rs 3,121.1 crore. This is the eighth consecutive quarter of sequential revenue growth. Still, its stock took a beating.

    What particularly stood out in Mindtree’s Q1FY23 results was the expansion in its EBIT margin by 30 bps QoQ to 19.2%. This is especially commendable in an environment where tier-I IT companies like TCS and HCL Technologies reported a contraction of 190 bps and 100 bps QoQ, respectively in the same quarter. Mindtree’s focus on mining its accounts, especially its top 100 customers aided both revenue growth and margin improvement for the company, according to its management. Basically, Mindtree laid emphasis on extracting more business from its existing clients at reasonable margin levels.

    Revenues from North America grew over 8% QoQ (75% of revenue) in Q1FY23. But investors are fretting over a slowdown in the US and other western countries. This led the  Nifty IT index to fall by over 1.5% on Thursday as the US’ 40-year high consumer inflation of 9.1% in June exacerbated fears of a recession due to a likely aggressive rate hike by the US Federal Reserve. Additionally, the IMF cut the country’s GDP growth forecast to 2.3% from 2.9% recently. Investors fear an economic slowdown in the US and Europe will slow client spending on discretionary technology upgrades. Understandably, Mindtree’s management remained cautiously optimistic on the growth outlook for H2FY23.

    1. Delta Corp: This casino company’s stock has been falling since Superstar Rakesh Jhunjhunwala started selling his stake in the company in early June. That month, Jhunjhunwala sold around 3% stake in the company. The stock tanked 10% and hit a 52-week low of Rs 162.1 on June 16. Junjhunwala and his associates currently hold 3.3% stake in the company, down from 6.17% at the beginning of June. What is bemusing investors is that Jhunjhunwala booked profits ahead of the company swinging back into a net profit of Rs 57.1 crore in Q1FY23 against a loss of Rs 28.9 crore in Q1FY22. Its revenues also jumped 2.3X YoY in Q1FY23.

    After Jhunjhunwala’s partial exit from the stock, came the news of its subsidiary–Deltatech Gaming– filing a draft prospectus for an IPO. Deltatech Gaming is planning to raise Rs 550 crore through the IPO. The company plans to use the funds to promote organic growth, do business promotions and strengthen its technology. But there is another headwind that investors might have to contend with. The GST Council is pondering over whether to impose a 28% GST on casinos and online gaming. This will impact Delta Corp’s business. For now, the group of ministers mulling over this issue still stand by their 28% GST rate recommendation, but a decision has been deferred.

    1. Aurobindo Pharma (Auro Pharma): This pharmaceutical company withdrew the proposed stake sale of its arm, Eugia Pharma Specialties on Monday, due to valuation differences, according to reports. If the deal had gone through, valued at $3.4-$4 billion, it could have been the largest deal in the injectables businesses in India. Blackstone and Baring PE Asia were the front runners in the proposed deal to buy a stake in Eugia Pharma.

    The buyers wanted to split Auro Pharma and spin off the injectables business, Eugia Pharma, into a separately listed company, according to reports. Auro Pharma’s injectables segment, which includes Eugia Pharma, is a major revenue contributor and contributed 26.8% of the total revenue in Q4FY22. Auro Pharma is an export-focused company, deriving over 75% of its revenue from the US and Europe. Given the bleak outlook in the US businesses due to intense competition and weak Q4FY22 results, the company’s stock fell around 42% from its 52-week high and currently trades near its 52-week low.

    In FY22, to counter the pricing pressure, the drug maker launched 10 injectable products in the US. According to its FY22 annual report, growing the injectable business continues to be among the top priorities for the company. The management expects the growth momentum in injectables to continue in FY23 despite price erosion on the back of new product launches.

    1. PI Industries: This agrochemical company’s stock rose 10.7% over the past month till Thursday, outperforming the Nifty 50 index by 9.7% and the agrochemical industry by 5.9% over the same period. This rise over the past month is most likely due to brokerages like Prabhudas Lilladher and ICICI Direct expecting the company to outperform its industry in FY23 and also benefit from the monsoon season. According to Prabhudas Lilladher, agrochemical companies are expected to see lower growth and margins due to the later-than-expected monsoon and elevated raw material costs. Companies with high exposure to the domestic market are expected to be the worst hit. However, companies like PI Industries which are export-oriented will be able to offset high input costs, added Prabhudas Lilladher. Exports accounted for 75% of the company’s total revenue in Q4FY22. The positive outlook of brokerages on the company is reflected in this screener with Nifty 500 companies that are brokers’ top picks. According to Trendlyne’s Forecaster estimates the company’s net profit and revenue is expected to grow 20.1% YoY and 18.6% YoY in Q1FY23, respectively.

    The management gave a revenue guidance of 18-20% for both its exports and domestic revenues in FY23. The company already has a strong export order book of $1.4 billion and expects to bag more orders in FY23. Favourable crop prices in the international market could lead to robust growth in exports in FY23, according to reports. The company’s export CSM (custom synthesis manufacturing) segment contributes 75% to total revenue, allowing the company to easily pass-on raw material prices. This would allow its margins to remain stable as the impact of the sharp rise in raw material prices will be reduced, the management added. The company also increased its capex to Rs 500 crore for FY23, compared to Rs 320 in FY22. This capex increase comes as it plans to increase its plant capacity by 1.5X this fiscal year. The company also plans to expand into the pharmaceutical sector and non-agro chemical segments, through acquisitions and new product launches in FY23.

    1. Ceat: This auto tyre company’s stock is rising for four consecutive sessions gaining 9% in the past week. It was also one of the top gainer stocks on Thursday, rising nearly 5% in trade. The company recently launched its ultra-high-performance tyre for the luxury segment. This bodes well for the company as reports suggest luxury car sales are growing in double-digits in 2022. Reports suggest that 17,000 luxury cars were sold in India from January-June in 2022, which is an increase of over 55% from a year ago.

    The stock is also rising in anticipation of better Q1FY23 results, which are expected to be released on Wednesday. A report from Nirmal Bang suggests that tyre companies are likely to see single-digit growth in revenue, mostly by 2-4% QoQ because of an increase in OEM (original equipment manufacturing) demand, higher volumes, and price hikes of 2-3% taken in Q1FY23. Also, Nirmal Bang expects that with the increase in two-wheeler demand, OEM sales will go up this quarter. However, margins will still be low in Q1FY23 given commodity cost pressures. As inflation is slightly low and commodity costs have eased, the positive effect on margins is likely to show up in Q2FY23. Trendlyne’s Forecaster estimates show that revenue is expected to grow 2% in Q1FY23 and the company is likely to report an average net profit of Rs 11.8 crore.

    This stock also shows up in the screener where mutual funds decreased their holding in the past month. Although the total change in holdings is marginal (0.2% down), the sentiment from investors largely remains mixed. Trendlyne’s Forecaster shows eight analysts recommend a ‘Buy’ on the stock, while five recommend a ‘Sell’, and three recommend to ‘Hold’ the stock.

    Trendlyne's analysts identify stocks that are seeing interesting price movement, analyst calls, or new developments. These are not buy recommendations.

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    15 Jul 2022
    Good days coming for FMCG? | Stocks with share prices rising ahead of results

    Good days coming for FMCG? | Stocks with share prices rising ahead of results

    A new earnings season for the new financial year has begun. This is a critical quarter for investors: while company CEOs like to paint a pretty picture in their forecasts, the Q1 results will give everyone a dose of reality.

    It's already clear that Indian IT is feeling the heat of a global slowdown. This sector was a pandemic star, with soaring IT spending during lockdowns. However, other previously beaten down sectors like FMCG may now see a recovery, giving investors a ray of hope.  

    In this week’s Analyticks:

    1. The FMCG sector gets a boost as  commodity prices cool off
    2. Screener: Companies seeing their stock prices rise ahead of Q1 results

    Let’s get into it.


    The FMCG sector is set to post another weak quarter. But is the worst finally over?

    There is a saying that ‘When you hit rock bottom, you can only go up’. After the Russia-Ukraine conflict broke out, commodity prices witnessed ‘unprecedented’ levels of inflation, as Hindustan Unilever’s chairman put it.

    This meant a hard time for India Inc, but it was the common man who bore the brunt as price increases were seen in virtually every product, from onions to cooking oil. Now, there are some signs of relief. 

    Consumer price inflation or CPI fell from peak levels of 7.79% in April 2022 to 7.01% in June 2022. Although the CPI is still above its tolerance levels, the RBI expects inflation levels to gradually ease in H2FY23 (contrast this to the US economy, where CPI for June has hit an eye-watering 9.1%). 

    In other good news for India, the southwest monsoon covered the entire country on July 2, six days in advance. According to the India Meteorological Department, between June 1 and July 12, India’s cumulative rainfall was 9% over its long-term average. This definitely bodes well for consumer demand in rural India, whose fortunes depend on a bumper kharif season. 

    This helps the FMCG sector, which has been struggling with input costs. In just the past one month, the Nifty FMCG outperformed the Nifty 50 by over 10 percentage points. 

    Palm oil, which is a key input for FMCG players like Hindustan Unilever, Godrej Consumer, Britannia and Nestlefell over 35% in price since May 2022. Notably, India imports 95% of its palm oil requirements from countries like Indonesia and Malaysia. Back in May 2022, Indonesia relaxed its export restrictions, which ultimately eased the tight supplies of palm oil. 

    Moreover, Brent crude spot prices fell by over 10% from their peak levels of $120/bbl on fears of a global recession. This will especially benefit FMCG players in the form of reduced packaging costs. It’s worth noting however, that oil prices have been very volatile, and may rise again when Chinese lockdowns end.

    While the dark clouds over this sector are beginning to clear, Q1FY23 has proved to be yet another challenging quarter. 

    FMCG players are in for yet another forgettable quarter

    Successive price hikes taken by FMCG companies have impacted consumer demand, especially in rural regions in Q1FY23 as well. Companies like Marico witnessed significant downtrading in their edible oil brand ‘Saffola’ as consumers switched to economy labels like Sunpure and Fortune. Moreover, the company witnessed a 1-2% volume fall for its flagship product ‘Parachute’ despite passing on the benefit of price deflation for copra, a key input, onto consumers. 

    On a positive note, Dabur and Godrej Consumer witnessed double-digit revenue growth for their personal care portfolio. Dabur also saw strong traction for its food and beverage vertical as out-of-home consumption resumed in Q1FY23. 

    However, input cost pressures will weigh negatively on the gross margins of FMCG players in Q1FY23. Even though the prices of edible oils softened at the end of the quarter, FMCG companies consumed high-cost inventory overall. 

    Green shoots of recovery might appear from Q2FY23

    FMCG players generally carry two months of inventory and have some forward contracts in place to satisfy consumer demand. Hence, they will see the benefit of lower edible oil prices on their gross margins only from September 2022, according to Edelweiss. Basically, investors will see a real improvement in gross margins somewhere in H2FY23. 

    Consensus estimates from Trendlyne’s Forecaster see FMCG players clocking 12%+ net profit growth on an average in FY23. However, these estimates haven’t been revised upwards in the last 60 days as market forces remain cautious of the sustainability of this recent cool-off. 

    Notably, the actual cool-off in edible oil prices began only in June 2022, and it is still early to judge if the trend will continue. Crude oil is operating at higher levels despite recent corrections. While ICICIDirect does anticipate further correction in commodity prices in the next 3-6 months backed by interest rate hikes, uncertainty in the macro-economic environment remains. 

    However, if commodity prices do head back down to their median levels, FMCG players will be able to pass on this benefit to the consumers. This will then stir-up demand and positively drive companies’ sales volume growth in H2FY23.

    According to HUL’s chairman Nitin Paranjpe, the FMCG sector is still nowhere close to its normal health. However, there is a clear signal that better times lie ahead of it with a normal monsoon season on the cards and commodity prices down from their peaks. 


    Screener: Banking and Finance stocks see a rise in their prices ahead of results

    This screener looks at companies that have seen their stock price rise in the past week, ahead of their results.

    The screener has 75 companies from the Nifty 500 and 14 from the Nifty 50. The Banking and Finance sector is especially well-represented,  with companies like HDFC Bank, Angel One, Axis Bank, Bank of Maharashtra, and Federal Bank seeing stock prices rise. 

    Angel One rose 7.1% in the past week, ahead of its result release on Thursday. The stock has given returns of 32.5% in the past year, supported by a 2X growth in net profit. This along with good operational numbers released in the past week has put faith in the company for further growth in Q1FY23. 

    Hindustan Unilever’s stock saw a price rise of 4.1% in the past week with its results releasing next Tuesday. With a YoY net profit growth of 11.1% in FY22, this FMCG major has done well despite it being a tough time for the FMCG sector. 

    With Oberoi Realty releasing its results on Friday, the company’s stock saw a rise of 9.7% in the past week despite house sales going down by 15% in Q1FY23. The stock gave healthy returns of 20%+ in the past year while its TTM net profit rose by 40%+ YoY.

    You can find some popular screeners here.

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    13 Jul 2022, 12:02PM
    Chart of the week: Lower food inflation brings June CPI below estimates

    Chart of the week: Lower food inflation brings June CPI below estimates

    The world is battling high inflation, and India is no different. After rising to above 7% in May, India’s consumer price inflation print again stayed above that level in June at 7.01%. This is well above the Reserve Bank of India’s Monetary Policy Committee’s tolerance limit of 6%. The slight drop in June’s inflation level was due to a fall in edible oil prices. 

    Inflation in food and beverages, which has the largest weightage (45.9%) in the CPI basket, fell marginally (28 basis points to 7.56%) as a result of the fall in edible oil prices. As a result CPI as a whole fell marginally MoM in June. 

    The other major contributors to CPI like fuel, clothing and footwear, and housing continued to rise. Fuel and lighting inflation rose by more than 10% in June, after dipping to 9.54% in May. This shows that energy costs remain high for consumers. Consumers will be hoping that the recent fall in crude oil prices will ease some of this pain in the coming months. 

    Overall however, the June CPI number was slightly lower than the estimated 7.1%. This has led Citigroup and Barclays to project a smaller interest rate hike from RBI in their MPC meet in August, with both predicting a 35 bps increase. 

    A Reuters poll ahead of the June CPI data release had economists predicting that inflation will persist into the second half of the year. Once the wholesale price index (WPI), or inflation at factory gate is released later in the week, investors will be able to assess how pervasive this phenomenon might be.

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline created a screener All results declared - …
    12 Jul 2022, 11:20PM

    All results declared - ongoing quarter

    Stocks whose results have been declared for the June quarter - Q1FY23
    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline created a screener Companies beating their industry …
    12 Jul 2022, 12:34PM

    Companies beating their industry consensus recommendation by analysts

    Stocks beating their industry consensus view (Rating Scale: 1 is Strong Buy, 2 is Buy, 3 is Neutral, 4 is Sell, 5 is Strong Sell)
    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline created a screener Test
    11 Jul 2022

    Test

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    11 Jul 2022
    Five analyst picks for Q1FY23 earnings season

    Five analyst picks for Q1FY23 earnings season

    By Suhas Reddy

    With the new earnings season underway, we looked at analysts' preview calls on various sectors and picked out the companies that they expect to do well in Q1FY23.

    1. Mahindra & Mahindra: IDBI Capital’s Mahesh Bendre and Pratik Desai believe the Indian auto sector is on the path of recovery, led by the passenger vehicle (PV) and commercial vehicle (CV) segments gaining traction. The analysts’ top picks in the sector are Mahindra & Mahindra (M&M), Maruti Suzuki India, Sona BLW Precision Forgings, and SJS Enterprises. They expect M&M’s stock to have the highest upside among the top picks. The analysts have a ‘Buy’ rating on M&M with a target price of Rs 1,643, indicating an upside of 41.5%.

    Bendre and Desai highlight the company’s sales volume growth in all its segments in June, and expect the company to maintain this growth momentum throughout FY23. “The company’s PV Sales compared to pre-pandemic June-19 month are 43% higher,” the analysts said. They expect the company’s revenue to grow on the back of a robust order book and new product launches. 

    1. Larsen & Toubro: Prabhudas Lilladher’s analysts Amit Anwani and Nilesh Soni expect capital goods companies to report healthy revenue growth in Q1FY23. They see growth on the back of a low base last year, a pick-up in execution of projects, and the Centre’s infrastructure development push. However, they also expect margins to fall due to supply chain disruptions, elevated commodity prices and high freight costs. The analysts’ top picks from this industry are Larsen & Toubro (L&T), Bharat Electronics, and Siemens. Among these stocks L&T has the highest upside. The analysts have a ‘Buy’ rating on L&T with a target price of Rs 2,091, an upside of 25.5%.

    “We expect the company’s consolidated revenue to grow 18% YoY in Q1FY23,” the analysts said. This growth is likely to be led by segments like IT, infrastructure, and hydrocarbons. The analysts are also upbeat on the company’s order flow as it announced many orders in the range of Rs 7,000-15,000 crore.  

    1. Infosys: ICICI Securities’ analysts Aniket Pande and Heenal Gada maintain their ‘Underweight’ rating on the Indian IT sector as they believe the peak revenue growth momentum period is over. They also expect large deal wins and hiring momentum to slow down in FY23. The analysts anticipate demand to moderate due to the economic slowdown in the US and Europe. The analysts picked Tata Consultancy Services and Infosys to perform better than the industry in FY23. Of the two stocks, they give Infosys a higher upside. The analysts upgraded their rating on Infosys to ‘Hold’ from ‘Reduce’ and increased their target price to Rs 1,464 from Rs 1,385.

    This comes after Infosys’ stock price fell 25% over the past three months. Their outlook on the company improved as they believe the company is well equipped to deliver industry-leading growth even during an economic slowdown. The analysts expect revenue growth to be driven by cobalt cloud capabilities, execution of mega-deals and potential market share gain in large vendor deals. “We believe Q1FY23 will be the bottom for margins for the company and margins will gradually improve from thereon,” the analysts said. They estimate the company’s revenue to grow by 21.9% YoY in Q1FY23.

    1. Bharti Airtel: This telecom company is ICICI Direct’s analyst Bhupendra Tiwary’ top pick in the telecom space. “We see subscriber addition momentum remaining muted amid sim consolidation due to tariff hike,” Tiwary says in this telecom sector report.  He has a ‘Buy’ rating on Bharti Airtel with a target price of Rs 860. This indicates an upside of 29.9%.

    “The reported average revenue per user is likely to be up 3% QoQ at Rs 184 as some residual tariff hike pass-through will be seen,” Tiwary says. He also predicts that the company will add 2 million mobile subscribers, and the wireless revenue rising 3.8% QoQ at Rs 18,278 crore. The analyst adds, “India non-wireless revenues’ traction should remain robust, especially broadband and enterprise. He expects the company to report revenue growth of 3.9% QoQ to Rs 32,739 crore, and a profit of Rs 2,264 crore. 

    1. Oil And Natural Gas Corporation (ONGC): As the Centre imposed export duties on exports of petrol, diesel, and aviation fuel, analysts Harshad Katkar, Nilesh Ghuge, Akshay Mane, and Rutvi Chokshi have turned cautious on the oil and gas space. In their report on the sector,  the analysts from HDFC Securities maintain a ‘Buy’ on ONGC with a target price of Rs 184, indicating an upside of 46.7%. 

    According to the analysts, stocks from the oil and gas sector declined as investors didn’t appreciate the new levies applied to the sector. They say that these taxes will adversely affect ONGC. For the company, “we bake in a lower net crude oil price realisation of $80 and $70 per barrel vs $93 and $79 per barrel earlier for FY23 and FY22, respectively,” say Katkar, Ghuge, Mane and Chokshi.They also stay optimistic that these levies will be reduced or withdrawn as inflation gets under control. This is corroborated by the Centre’s stance that it will remove this ‘windfall’ tax on these products if there is a $40 fall in crude oil prices.

    Note: These recommendations are from various analysts and are not recommendations by Trendlyne.

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    08 Jul 2022
    Five Interesting Stocks Today

    Five Interesting Stocks Today

    1. Kotak Mahindra Bank: This bank stock outperformed its industry by 5.8% over the past 90 days, but underperformed the Nifty Bank index over the last two years, according to a report by Goldman Sachs (GS). Still, this doesn’t concern the brokerage as it upgraded its rating on the stock to ‘Buy’ from ‘Neutral’. GS believes that the bank is well-equipped to utilize its excess capital to drive a higher return on equity (ROE.) If the bank can successfully utilize its retail assets it can touch the market capitalization of $100 billion by FY27, the brokerage says. HDFC Bank is the only other stock in this sector to achieve that milestone.

    Apart from focussing on operating profits, asset quality and ROE, Kotak Mahindra is also working on technological upgrades for its systems. However, it will take 3-5 years for the company to completely reap the benefits of these upgrades. The Reserve Bank of India also fined the bank Rs 1.05 crore for a lapse in crediting the amount to a depositor within a stipulated time. The company had to issue a clarification regarding this in its BSE filing saying that the fine does not have ‘any adverse impact on the bank’. With its aim to improve operational process and better digital adoption by its customers, it will have to be careful to avoid such lapses in the future.

    1. Sobha: This realty stock soared nearly 7% on the bourses on Thursday after it announced its operational update for Q1FY23. It was trading with 3.5X of its weekly average trading volumes on the bourses. The stock is performing well over the past month and is up 23.5%, outperforming the Nifty 500 index by 25.5%. The Q1FY23 operational updates show that its sales bookings increased 67.6% YoY to Rs 1,145.5 crore. The company also achieved its highest ever sales volumes during the quarter. The management expects to sustain this growth going forward in FY23. The company also announced the launch of three new residential projects in Bengaluru, with over 2 million square feet of saleable area.

    Currently, with rising inflation, there are worries about rising construction costs. Reports suggest that realty companies are facing a rise in construction costs by 12-15%. In its quarterly update filing, the company says it will hike prices across its projects to mitigate the impact of rising costs.

    With the RBI trying to control inflation by hiking its benchmark lending rate, home loans are more expensive than in the last two years. Although this did not have a detrimental effect on housing demand in Q1FY23, the trickle-down effect will take some time to show up, if the central bank keeps raising rates. According to sector reports from Motilal Oswal, the effect of interest rate hikes on demand will reflect only when home loan rates go beyond 8.5%.

    1. Titan: This jewellery maker’s stock rose 5.7% on Thursday after it released its Q1FY23 business update. Titan’s sales jumped 205% YoY in Q1FY23 helped by a low base last year due to lockdowns. Despite the low base, its three-year sales CAGR remains healthy at 20.5%. This positive Q1FY23 business update comes after weak Q4FY22 results due to Omicron-induced lockdowns in January. The sharp rise in sales was led by the jewellery segment, which constitutes about 88% of the company’s total revenues. Sales from this vertical jumped three times YoY in Q1FY23 on the back of strong demand during Akshaya Tritiya festival in May, after two years of lockdowns during the same period.

    The company posted growth across all verticals. While watches and wearables’ revenue rose 158% YoY eyecare sales increased by 176%. According to its FY22 annual report, Titan will continue to focus on network expansion across channels and segments to drive revenue growth.

    With a good start to FY23, Trendlyne’s Forecaster estimates show that the average of consensus estimates revenue growth for Titan in FY23 is 18.3%. Brokerages are optimistic about the company and as a result, it shows up in this screener which lists stocks with high analyst ratings that have an upside of at least 20% from their current price.

    1. Godrej Consumer Products (GCPL): This fast-moving consumer goods company’s stock rose by 5.7% on Wednesday after it announced its Q1FY23 quarterly update. This helped the company outperform the Nifty 50 index by 9.5% over the week and also outperform the personal products industry by 5.3% over the past month. The company expects to deliver double-digit sales growth in Q1FY23 on a high base in its India business. It derives 56.1% of its revenue from its India operations. The personal care segment led growth in the Indian business was driven by the personal wash and hair wash categories, the company said. GCPL’s revenue growth was also aided by price hikes, as the rural market recovery was weaker than the urban market, impacting volumes.

    GCPL expects its Indonesian business’ sales volume to drop to high single-digits due to a high base last year in the hygiene segment. The Indonesian market contributed 13.8% of its revenue in Q4FY22. The other international regions like Africa, the USA, Latin America, and West Asia saw robust sales growth momentum and it expects double-digit sales growth in these regions. These markets contributed 32% to the company’s total revenue in Q4FY22.

    The company expects a fall in its EBITDA margins and profit on a YoY basis in Q1FY23. It cites high input costs, elevated advertising expenses and a fall in sales volume in Indonesia. However, GCPL expects margins to improve going ahead as inflationary pressures are likely to reduce due to a correction in palm oil prices and crude oil. Prices of palm oil fell by 43% as of July 7 from its record highs in March. It also expects a recovery in demand and consumption in the coming quarters. 

    1. Star Health & Allied Insurance Co: This health insurer’s stock rose 11.4% in trade on Thursday after the General Insurance Council released a monthly update for the general insurance industry. The stock was also the top gainer among Nifty 500 companies on Thursday. Star Health’s Q1FY23 gross direct premium written rose 13% YoY to 2,466.2 crore. Its June gross direct premium written rose 10.3% YoY to Rs 949.7 crore. However, the rise in stock price came despite the company’s market share in Q1FY23 falling by 40 bps YoY to 4.5% in the general insurance market. The rise in its stock price was also aided by Credit Suisse initiating coverage of the company with an ‘Outperform’ rating, according to reports. The brokerage said its view on the company’s prospects is because of its large agency network (5.5 lakh agents), continued expansion, and an attractive risk-reward ratio. The company’s retail health insurance is a high-growth industry and Star Health is well-placed to capture this growth as it is the largest player in the segment, the brokerage said.

    The investor presentation shows the company’s market share in the retail health insurance industry at currently more than 30% in terms of gross premium. The health insurer has nearly three times more agents than its next largest competitor. Looking ahead, the company expects its retail health segment to grow at a 20-25% CAGR over the next FY22-25, led by an increased focus on tier-2 and tier-3 cities, doubling of bancassurance channel to 8% in FY23, and increasing the share of digital issuance. But with the insurance regulator planning to allow life insurers to sell health insurance products, the positive outlook for this health insurer needs to be cautious.

    Trendlyne's analysts identify stocks that are seeing interesting price movement, analyst calls, or new developments. These are not buy recommendations.

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    07 Jul 2022
    Chart of the week: Analysts are positive on banks, NBFCs and packaged foods industries

    Chart of the week: Analysts are positive on banks, NBFCs and packaged foods industries

    With the new earnings season about to start, investors are trying to figure out which stocks are likely to see a good result, despite rising inflation and a volatile global economy. We checked the Trendlyne Forecaster estimates to identify the companies and industries analysts are most bullish on.

    Here we first take a look at industries that have a ‘Strong Buy’ and ‘Hold’ stance from analysts. We then check revenue growth expectations within these industries for some Nifty 50 companies. 

    Banks, NBFCs and packaged foods industries are among those  that the street is bullish on. Analysts have a ‘strong buy’ stance for these three industries. 

    Within banks, Bajaj Finance has the highest expected revenue growth of 35.6% in Q1FY23. But on a QoQ basis, the expectation is of a muted 0.6% revenue growth. HDFC Bank andState Bank of India’s Q1FY23 expected YoY revenue growth, according to Trendlyne’s Forecaster estimates are 11.6% and 8.4%, respectively. Tata Consumer, part of the packaged foods industry, is expected to post revenue growth of 13.7% YoY, and  7.8% on a QoQ basis in Q1FY23.

    If we look at the industries which have consensus stance of ‘Hold’ from analysts, these are pharmaceuticals, iron & steel/intermediate products, cement & cement products, 2/3 wheelers and marine port & services. Trendlyne Forecaster’s consensus estimates show that the street expectsAdani Ports & SEZ Q1FY23 revenue to fall by 5.6% YoY, but on a QoQ basis, the street expects a near 12% rise in revenues. 

    In Iron & Steel, JSW Steel is expected to post revenue growth of nearly 73% YoY in Q1FY23, indicating that it will probably continue its stellar run of revenue growth, despite recent export restrictions. On a QoQ basis, revenue growth is expected to be a more moderate 6.5%. 

    In the auto industry, Eicher Motors’ Q1FY23 revenue is expected to grow by 69.2% YoY (on a low base) and 4.6% QoQ. And in pharmaceuticals, Sun Pharmaceuticals and Dr. Reddy’s Laboratories’ revenues are expected to grow 8.6% YoY and 12.8% YoY, respectively, and 11.7% QoQ and 2.1% QoQ, respectively. 

    With many headwinds affecting industries across the board, let’s see if these companies meet or beat these consensus expectations in Q1FY23.

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    04 Jul 2022
    Five stocks beating their industry in analyst sentiment

    Five stocks beating their industry in analyst sentiment

    By Abhiraj Panchal

    1. Bharat Electronics: This defense public sector firm has 21 consensus recommendations from analysts of a ‘Strong Buy’, which is better than the industry consensus (which analysts rate as ‘Buy’). Out of 21 analysts, 17 have ‘Strong Buy’ recommendations on Bharat Electronics, as well as one ‘Buy’, ‘Hold’ and ‘Sell’. The company has a Trendlyne Durability score of 70, indicating strong financials. In FY22, the company’s revenue grew 9.6% YoY to Rs 15,599.7 crore and profit by 14.3% to Rs 2,398.9 crore. 

    According to Nilesh Soni from Prabhudas Lilladher, Bharat Electronics has a substantial order backlog and tender pipeline, and it is also diversifying into business verticals like EV batteries, medical equipment, etc. He further states, “order pipeline stands strong from the Akash weapon system, QRSAM, LRSAM, Naval equipment like a surveillance system, radars, and navigation systems”. Chirag Shah and Vijay Goel from ICICI Direct are also optimistic about the company’s prospects as it is diversifying into non-defense businesses and focuses on increasing exports. 

    1. Birlasoft: The consensus recommendation from 11 analysts on this IT consultancy services company is a ‘Strong Buy’. 10 analysts have a ‘Strong Buy’ ratings, while one analyst has a ‘Hold’ rating. The consensus recommendation on this company is better than the overall industry rating of ‘Hold’. The company has a Trendlyne Durability score of 75. In FY22, its revenue grew 16.2% YoY to Rs 4,130.3 crore ($523.4 million) and profit grew 44.5% YoY to Rs 463.6 crore.

    The company guided for $1 billion revenue in FY25, out of which it expects $800-$850 million to be contributed by organic growth. The remaining $150-$200 million will be contributed by inorganic opportunities. The company expects to meet its FY25 revenue target by winning more large contracts. Sameer Pardikar of ICICI Direct says “revenue growth is expected to be achieved via client mining, cross-selling, multi-year deals, expansion in Europe & APAC and focus on niche verticals”. He also estimates dollar revenue to grow at a 13.7% CAGR and margin to expand by 50 bps to 16% over FY22-24. 

    1. DLF: The consensus recommendation from 19 analysts on this real estate company is a ‘Buy’. Out of these 19, 14 analysts recommended a ‘Strong Buy’, two recommended a ‘Buy’, two a ‘Hold’ rating, and one had a ‘Strong Sell’ rating on this Gurgaon-based real estate developer. The consensus recommendation on this company is better than its industry’s rating (of ‘Buy’) and has a Trendlyne Durability score of 85. In FY22, the company’s revenue rose by 5.6% YoY to Rs 5,717.4 crore and its profit rose by 37.2% YoY to Rs 1,500.9 crore.

    The company’s pre-sales in FY22 grew 2.4X YoY to Rs 7,270 crore and beat its presales guidance of Rs 6,000-6,500 crore. The company’s overall sales margin grew by 15 percentage points to 51% in FY22. Brokerages like HDFC Securities and Edelweiss expect the occupancy rates in its office, retail, and residential portfolios to improve in the coming quarters and they both have a positive outlook on the company’s prospects. Amit Agarwal and Manan Shah of Edelweiss say the company “has aggressive launch pipelines to scale up the current portfolio and will be a key beneficiary when the commercial cycle recovers”. The management has guided robust exit rentals of Rs 4,400 - 4,500 crore for FY23, driven by new launches, higher retail yields and an increase in occupancy levels.

    1. Apollo Hospitals Enterprise: This healthcare company, with 21 analyst recommendations, has a consensus call of ‘Strong Buy’, better than the overall industry’s ‘Buy’ rating. 15 analysts have a ‘Stong Buy’ on the business, five have a ‘Buy’ rating, and one ‘Hold’. The company has a Trendlyne Durability score of 85. In FY22, the company reported revenue growth of 39% YoY to Rs 14,740.8 crore and profit growth of 601.9% YoY to Rs 1,055.6 crore. 

    Param Desai and Sanketa Kohale from Prabhudas Lialladher say, “Apollo Hospitals pursued aggressive expansion in the past few years, which has created a strong growth platform”. According to the company’s Q4FY22 earnings call,  it expects a total of $3 billion of gross merchandise value from its offline pharmacies ($2 billion), Apollo 24*7 ($500-700 million), and companies partnership with amazon ($500 million) in the next 3-4 years. The company also expects its offline pharmacy to continue to grow at 20% in FY23 due to store expansion for its diagnostic business. It expects the business to grow to Rs 1,000 crore within three years. Apollo 24*7 has earmarked Rs 400 crore marketing expenditure for FY23. 

    1. Tech Mahindra: This IT consulting and software company has a consensus recommendation of ‘Buy’ from 41 analysts, better than the industry consensus rating. Out of the 41 analysts, 25 have a ‘Stong Buy’ call, seven have a ‘Buy’, five a ‘Hold’, and two are at ‘Stong Sell’. The company has a Trendlyne Durability score of 75. In FY22, the company’s revenue grew by 18.4% YoY to Rs 45,758.3 crore and profit grew by 25.7% to Rs 5,566.1 crore. 

    According to the Q4FY22 earnings call transcript, the company’s new deal wins have amounted to $1 billion, constituting $366 million from the Enterprise segment, and the rest from communications, media, and entertainment (CME). The company has announced partnerships with Bharti Airtel to set up a joint 5G innovation lab to co-develop and market 5G in India. Tech Mahindra’s other recent collaborations include conversational-AI solutions with Yellow.ai, and collaboration with Cisco, and Celonis, among others, for the advancement in technology. 

    Analysts from ICIC Direct, IDBI Capital and Geojit BNP Paribas, among others, believe that Tech Mahindra’s new deal wins and its capabilities in new technology, like 5G, automation and AI could drive its future revenue growth.

    1
    Copy LinkShare onShare on Share on Share on
     
    more
    loading
    Logo Trendlyne

    Stay ahead of the market

    Company

    PrivacyDisclaimerTerms of Use Contact Us

    Resources

    Blog FAQsStock Market Widgets

    Copyright © 2025 Giskard Datatech Pvt Ltd